戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 tential role of each residue of this complex glycopeptide antibiotic.
2  is highly reproducible and selective toward glycopeptide antibiotics.
3 larization based method for the detection of glycopeptide antibiotics.
4  activities, and probably the structures, of glycopeptide antibiotics.
5 to desolvation of the ligand binding site in glycopeptide antibiotics.
6  the vancomycin and the teicoplanin class of glycopeptide antibiotics.
7 omycin, a member of the vancomycin family of glycopeptide antibiotics.
8 rinsic resistance to the vancomycin class of glycopeptide antibiotics.
9  showed a mechanistic distinction from other glycopeptide antibiotics.
10 s and keratinimicins are recently discovered glycopeptide antibiotics.
11  that by blocking autolysin function, type V glycopeptide antibiotics are promising antivirulence age
12                                              Glycopeptide antibiotics are regularly used in ophthalmo
13                                              Glycopeptide antibiotics are widely used in the treatmen
14 ichia coli, which is never challenged by the glycopeptide antibiotics because they cannot penetrate t
15             All the inducers identified were glycopeptide antibiotics, but teicoplanin, a membrane-an
16 -Ala cell wall precursor to d-Ala-d-Lac upon glycopeptide antibiotic challenge, displaying a potency
17                           Bleomycin (BLM), a glycopeptide antibiotic chemotherapy agent, is capable o
18 ible for biosynthesis of the vancomycin-type glycopeptide antibiotic chloroeremomycin was recently se
19 ted a streamlined total synthesis of the new glycopeptide antibiotic class by removing the challenges
20  class of glycopeptide antibiotics-the known glycopeptide antibiotic complestatin and a newly discove
21           To investigate, we used the type V glycopeptide antibiotic complestatin, which binds to pep
22 es seen in three other crystal structures of glycopeptide antibiotics complexed with peptide ligands.
23                                  Interest in glycopeptide antibiotics covers many scientific discipli
24                                 Like certain glycopeptide antibiotics (e.g., vancomycin), PGRPs kill
25                     The adamantyl-2 amide of glycopeptide antibiotic eremomycin (1a in Chart 1, AN090
26        Here, we investigate the experimental glycopeptide antibiotic, EVG7, in the context of rCDI.
27                                              Glycopeptide antibiotics (GPAs) are nonribosomal peptide
28 he discovery of vancomycin in the 1950s, the glycopeptide antibiotics (GPAs) have been of great inter
29                                          The glycopeptide antibiotics (GPAs) serve as an important ex
30                                     Although glycopeptide antibiotics (GPAs), including vancomycin an
31        Chloroeremomycin, a vancomycin family glycopeptide antibiotic has three sugars, one D-glucose
32                     The vancomycin family of glycopeptide antibiotics has been inspiring research in
33              Vancomycin, a widely prescribed glycopeptide antibiotic, has an oral bioavailability of
34                                              Glycopeptide antibiotics have long served as drugs of la
35                                           In glycopeptide antibiotics, however, these cooperative pro
36                      VanA-type resistance to glycopeptide antibiotics in clinical enterococci is regu
37 lently immobilising teicoplanin and/or other glycopeptide antibiotics in the pursuit of novel antibac
38 ence of resistance to vancomycin and related glycopeptide antibiotics is spurring efforts to develop
39 e bleomycins (BLMs) are structurally related glycopeptide antibiotics isolated from Streptomyces vert
40  oxide was functionalized with vancomycin, a glycopeptide antibiotic known to have a specific interac
41              We have developed a preclinical glycopeptide antibiotic, MCC5145, that has excellent pot
42 to protoplasts that were pretreated with the glycopeptide antibiotic phleomycin, a nonspecific DNA do
43                                       In the glycopeptide antibiotic producers Streptomyces toyocaens
44                            Second-generation glycopeptide antibiotics similar to vancomycin are in cl
45                          The biosynthesis of glycopeptide antibiotics such as vancomycin and other bi
46 ramoplanin is structurally less complex than glycopeptide antibiotics such as vancomycin, peptidomime
47  distinct hydroxyl groups within the complex glycopeptide antibiotic teicoplanin A2-2.
48                                  The natural glycopeptide antibiotic teicoplanin is used for the trea
49 ial interactions of the last line of defence glycopeptide antibiotic teicoplanin with an ocular mucin
50  quantitate the binding affinity between the glycopeptide antibiotics teicoplanin from Actinoplanes t
51 results suggest new strategies for designing glycopeptide antibiotics that overcome bacterial resista
52 nt of a class of highly potent semisynthetic glycopeptide antibiotics, the guanidino lipoglycopeptide
53 e essential to understanding the activity of glycopeptide antibiotics, the recognition of pathogens b
54 red two members of a new functional class of glycopeptide antibiotics-the known glycopeptide antibiot
55 ed total syntheses of vancomycin and related glycopeptide antibiotics, their agylcons, and key analog
56  internuclear distances from the 19F of this glycopeptide antibiotic to natural-abundance 31P and to
57 ws that the same H-bonding framework used by glycopeptide antibiotics to bind peptidoglycan termini i
58 nked the Lys-D-Ala-D-Ala binding epitope for glycopeptide antibiotics to three different carrier prot
59                                Vancomycin, a glycopeptide antibiotic used for Gram-positive bacterial
60                              Vancomycin is a glycopeptide antibiotic used for the treatment of Gram-p
61               Oritavancin is a semisynthetic glycopeptide antibiotic used to treat severe infections
62                    The sugar residues of the glycopeptide antibiotic vancomycin contribute to the coo
63                                          The glycopeptide antibiotic vancomycin has been widely used
64 ly established dimerization of the important glycopeptide antibiotic vancomycin in four different aqu
65                                          The glycopeptide antibiotic vancomycin is a mainstay in the
66 t the Amycolatopsis sp. BCA-696 produces the glycopeptide antibiotic vancomycin that inhibits the gro
67 sors in bacteria, which are resistant to the glycopeptide antibiotic vancomycin.
68  dipeptidase essential for resistance to the glycopeptide antibiotic vancomycin.
69 ery limited treatment options, primarily the glycopeptide antibiotic vancomycin.
70                     The structurally related glycopeptide antibiotics vancomycin, ristocetin A, and t
71                                  Using three glycopeptide antibiotics, vancomycin, teicoplanin, and t
72                        Vancomycin, a natural glycopeptide antibiotic, was used as the antibiotic of l
73                       Oritavancin is a novel glycopeptide antibiotic with concentration-dependent kil
74 al component of the mannopeptimycins, cyclic glycopeptide antibiotics with activity against drug-resi
75                                        Thus, glycopeptide antibiotics with enhanced antibacterial act
76 ycin, and we show that the activity of other glycopeptide antibiotics with this feature can also be s